AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFTAZIDIME PENTAHYDRATE
5 registrations across 3 African markets— 2 active
Markets with CEFTAZIDIME PENTAHYDRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CEFTAZIDIME FOR INJECTION 1g Powder For Solution For Injection | 🇰🇪Kenya | Guilin Pharmaceutical (Shanghai) Co., Ltd. | active | Nov 2030 |
| TAZIJECT*1G 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2009 |
| TAZIJECT_2G 2G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2009 |
| TAZIJECT-0.5G 0.5G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2009 |
| Ceftazidime pentahydrate Powder and solvent for solution for injection | 🇹🇿Tanzania | B&O PHARM | active | — |
CEFTAZIDIME PENTAHYDRATE in Africa — Regulatory Overview
CEFTAZIDIME PENTAHYDRATE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 2 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.